Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis

Journal of Applied Physiology

Volumn 86, Issue 5, 1999, Pages 1739-1744

  Scott, J A ^a   McCormack, D G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aminoguanidine; Enzyme inhibition; Selective

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; ENZYME ACTIVITY; ENZYME INHIBITION; HEMODYNAMICS; LUNG; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; THORACIC AORTA;

EID: 0032951306     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.86.5.1739     Document Type: Article

References (24)

1. Alden, K. J., S. J. Motew, A. C. Sharma, and J. L. Ferguson. Effect of aminoguanidine on plasma nitric oxide by-products and blood flow during chronic peritoneal sepsis. Shock 9: 289-295, 1998.
2. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
3. Buga, G. M., J. M. Griscavage, N. E. Rogers, and L. J. Ignarro. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73: 808-812, 1993.
4. Fox, G. A., N. A. M. Paterson, and D. G. McCormack. Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. J. Cardiovasc. Pharmacol. 28: 30-35, 1996.
5. Fox, G. A., N. A. M. Paterson, and D. G. McCormack. Effect of inhibition of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1377-H1382, 1994.
6. Griscavage, J. M., J. M. Fukuto, Y. Komori, and L. J. Ignarro. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group: role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. J. Biol. Chem. 269: 21644-21649, 1994.
7. Hock, C. E., K. Yin, G. Yue, and P. Y. Wong. Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H843-H850, 1997.
8. Julou-Schaeffer, G., G. A. Gray, I. Fleming, C. Schott, J. R. Parratt, and J.-C. Stoclet. Activation of the L-arginine-nitric oxide pathway involved in vascular hyporeactivity induced by endotoxin. J. Cardiovasc. Pharmacol. 17, Suppl. 3: S207-S212, 1991.
9. Liaudet, L., A. Rosselet, M. D. Schaller, M. Markert, C. Perret, and F. Feihl. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J. Infect. Dis. 177: 127-132, 1998.
10. Liu, S. F., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit. Care Med. 24: 1219-1225, 1996.
11. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. Altered responses to infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
12. Martin, C. M., A. Yaghi, W. J. Sibbald, D. G. McCormack, and N. A. M. Paterson. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am. Rev. Respir. Dis. 148: 164-172, 1993.
13. Misko, T. P., W. M. Moore, T. P. Kasten, G. A. Nickols, J. A. Corbett, R. G. Tilton, M. L. McDaniel, J. R. Williamson, and M. G. Currie. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233: 119-125, 1993.
14. Nathan, C., and Q.-W. Xie. Nitric oxide synthases: roles, tolls and controls. Cell 78: 915-918, 1994.
15. Ruetten, H., G. J. Southan, A. Abate, and C. Thiemermann. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol. 118: 261-270, 1996.
16. Scott, J. A., M. Machoun, and D. G. McCormack. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. J. Appl. Physiol. 80: 271-277, 1996.
17. Southan, G. J., and C. Szabó. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51: 383-394, 1996.
18. Szabó, C., G. J. Southan, and C. Thiemermann. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 91: 12472-12476, 1994.
19. Wolff, D. J., and A. Lubeskie. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch. Biochem. Biophys. 316: 290-301, 1995.
20. Wolff, D. J., A. Lubeskie, and C. Li. Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthase inhibitors. Arch. Biochem. Biophys. 338: 73-82, 1997.
21. Wu, C.-C., S.-J. Chen, C. Szabó, C. Thiemermann, and J. R. Vane. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114: 1666-1672, 1995.
22. Wu, C. C., H. Ruetten, and C. Thiemermann. Comparison of the effects of aminoguanidine and Nω-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur. J. Pharmacol. 300: 99-104, 1996.
23. Yaghi, A., N. A. M. Paterson, and D. G. McCormack. Vascular reactivity in sepsis: importance of controls and role of nitric oxide. Am. J. Respir. Crit. Care Med. 151: 706-712, 1995.
24. Yoshizumi, M., M. A. Perella, J. C. Burnett, Jr., and M.-E. Lee. Tumor necrosis factor down-regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209, 1993.